Test a jaundice device for newborns in low-resource settings
Part of Genetic & congenital clinical trials.
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your newborn is being cared for in the neonatal ward at Queen Elizabeth Central Hospital or Kamuzu Central Hospital
- Your baby is younger than 28 days old
- Your baby is at risk for jaundice or is currently receiving blue light treatment for jaundice
- A parent or legal guardian can give permission for the study
- Your baby can have a small blood sample taken (like a heel stick) if the clinician needs it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies if a blood test measuring the ratio of two proteins can better predict brain damage from severe jaundice than the current standard test. It aims to help doctors identify babies who need faster treatment.
This trial compares two medicines, fenofibrate and phenobarbitone, added to standard light therapy to see which works better at lowering bilirubin levels in full-term newborns with jaundice. It aims to find a faster or more effective way to treat jaundice and reduce the need for more intensive treatments.
This study tests a device that measures jaundice (yellowing of the skin) through the skin rather than with a blood test. It may help newborns avoid a needle stick.
This study tests a new phototherapy (special light treatment) device to treat newborn jaundice. It may help by seeing whether this device can treat jaundice safely and effectively.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
This trial tests if a skin light meter can accurately measure jaundice (bilirubin) in newborns with different skin tones. It may help reduce the need for blood tests.
Hear when a new Hyperbilirubinemia, Neonatal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.